Take-home naloxone

T Kumar, H Rosenberg - CMAJ, 2017 - Can Med Assoc
In 2016, naloxone was removed from the federal Prescription Drug List, and the National
Association of Pharmacy Regulatory Authorities reclassified the drug as Schedule II …

The over‐regulation of pharmacist services: Why over‐the‐counter naloxone should spark conversation about a “standard of care” regulatory approach

AJ Adams, TP Frost - Journal of the American College of …, 2023 - Wiley Online Library
Abstract In March 2023, the US Food and Drug Administration approved the first naloxone
nasal spray to be available over‐the‐counter without a prescription. Naloxone nasal spray …

Implementation of a naloxone dispensing program in a grocery store–based community pharmacy

DM Wilkerson, BK Groves… - American journal of health …, 2020 - academic.oup.com
The epidemic of opioid-related drug overdose deaths is a serious public health issue
impacting the United States. In 2016, 42,249 people in the United States died of an …

Laws mandating coprescription of naloxone and their impact on naloxone prescription in five US states, 2014–2018

TC Green, C Davis, Z Xuan… - American journal of …, 2020 - ajph.aphapublications.org
Objectives. To examine early impacts of laws that require naloxone to be prescribed to
patients at increased overdose risk. Methods. Using data from 2014 to 2018 from a large …

Pharmacist furnishing of naloxone in California: A follow-up analysis

T Puzantian, JJ Gasper, CM Ramirez - Journal of the American Pharmacists …, 2021 - Elsevier
Background Increasing naloxone access in communities has been a priority to mitigate the
increasing rate of opioid-related overdose deaths. Objectives The aims of this telephone …

Bringing naloxone to ground zero: Huntington, West Virginia

C Babcock, N Rockich-Winston, C Booth - Journal of the American …, 2017 - japha.org
The opioid epidemic in Appalachia reached a plateau in Huntington, a town of just under
50,000 people. 1 West Virginia itself was ranked second in heroin fatality rates by the …

Considering the potential benefits of over-the-counter naloxone

KE Evoy, LG Hill, CS Davis - Integrated Pharmacy Research and …, 2021 - Taylor & Francis
Since 1999, annual opioid-related overdose (ORO) mortality has increased more than six-
fold. In response to this crisis, the US Department of Health and Human Services outlined a …

FDA approves first intranasal naloxone product.

K Traynor - American Journal of Health-System Pharmacy, 2016 - search.ebscohost.com
The article reports on the approval by the US Food and Drug Administration (FDA) of
Narcan, a naloxone hydrochloride product from pharmaceutical company Adapt Pharma that …

Naloxone over the counter: Increasing opportunities and challenges for health providers

AD Ardeljan, B Fiedler, L Fiedler, GR Luck… - The American Journal …, 2023 - amjmed.com
On November 15, 2022, the US Food and Drug Administration (FDA) issued a request for
data from manufacturers of naloxone to support a switch from prescription to over-thecounter …

Nonprescription naloxone: pros and cons

KMS Bastianelli, KK Orr - Journal of the American Pharmacists …, 2014 - japha.org
Nonprescription naloxone: Pros and cons In 2010, drug overdose deaths increased for the
11th consecutive year, causing 38,329 deaths in the United States. Nearly 60% of those …